ARCHIVES

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

This article is from The Cancer Letter archive.

Vol. 33 No. 06 | February 16, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Clinical Trials Approved By NCI

November 26, 2010

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

Abstracts From AACR Annual Meeting

May 21, 1976

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997